Entero Healthcare Solutions

Sector: Healthcare

Followers

0
0
1
1
.
3
3
9
9
1
1
,
1
1
80.60 (7.24%)

As on 06 Jan, 2026 | 16:07

Open Trading A/c
Day Range
1,092.10
1,224.60
LH
52 Week Range
944.00
1,563.90
LH
Volume
* i
Bid / Ask
1,617,671.00
1,193.10 / 435.00

Entero Healthcare Solutions Announcements

Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018.

06 Jan, 2026 | 10:10am • Source: NSE

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2025

06 Jan, 2026 | 10:05am • Source: BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SMALLCAP World Fund, Inc.

31 Dec, 2025 | 12:47pm • Source: BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund

31 Dec, 2025 | 11:09am • Source: BSE

Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

23 Dec, 2025 | 04:44pm • Source: BSE

Intimation for grant of 73060 options pursuant to "Entero Employees stock options plan 2023" to the eligible employees of the Company.

06 Dec, 2025 | 07:08pm • Source: BSE

Affirmation of Credit Rating by India Ratings and Research

04 Dec, 2025 | 05:31pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meeting to be held on December 02, 2025 at 09:00 AM (IST)

27 Nov, 2025 | 06:01pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meeting to be held on November 21, 2025 at 10:00 AM (IST)

17 Nov, 2025 | 04:11pm • Source: BSE

Submission of Newspaper publication for unaudited financial result for the quarter and half year ended September 30, 2025.

14 Nov, 2025 | 11:09am • Source: BSE

Investor Presentation on Unaudited Financial Results for the Quarter and Half year ended September 30, 2025

12 Nov, 2025 | 09:56pm • Source: BSE

Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Acquisition

12 Nov, 2025 | 07:24pm • Source: BSE

Change in designation of Mr. Abhitesh Kumar from President- Retail Business and New Initiatives to Chief Growth Officer of the Company

12 Nov, 2025 | 07:18pm • Source: BSE

Submission of Monitoring Agency Report for the Quarter ended September 30, 2025

12 Nov, 2025 | 07:15pm • Source: BSE

Allotment of Equity Shares pursuant to exercise of ESOP under Employee Stock Option Scheme 2023

12 Nov, 2025 | 07:07pm • Source: BSE

Submission o Unaudited Financial Results for the quarter and half year ended September 30, 2025

12 Nov, 2025 | 07:02pm • Source: BSE

Outcome of Board Meeting dated November 12, 2025

12 Nov, 2025 | 06:50pm • Source: BSE

Intimation of Earnings call on unaudited Financial Results of the Company for the Quarter and half year ended September 30, 2025

07 Nov, 2025 | 06:04pm • Source: BSE

Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider...

29 Oct, 2025 | 11:24am • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meeting to be held on October 14, 2025 at 04:30 PM (IST)

08 Oct, 2025 | 05:24pm • Source: BSE